Search For "dgci"
Updated : 1 week, 3 days ago IST
New Delhi [India], September 14 (ANI): The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.
Updated : 2 months, 3 weeks ago IST
New Delhi [India], June 29 (ANI): The Mumbai-based pharmaceutical multinational Cipla, on behalf of the US pharma major Moderna, has requested for import and marketing authorisation of its COVID-19 vaccines.
Updated : 3 months ago IST
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin on Tuesday, sources said.
Updated : 5 months ago IST
New Delhi [India], April 23 (ANI): Zydus Cadila received emergency use approval from the Drugs Controller General of India (DGCI) on Friday for the use of 'Virafin', Pegylated Interferon alpha-2b (PegIFN) in treating moderate COVID-19 infection in adults.
New Delhi [India], April 23 (ANI): The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults.
Updated : 5 months, 1 week ago IST
Bengaluru (Karnataka) [India], April 14 (ANI): Private Hospitals and Nursing Homes Association's (PHANA) executive committee member Dr Rajashekar on Wednesday admitted that there was a shortage of Remdesivir doses for COVID-19 treatment and that the Drug Controller General of India (DGCI) ha
Updated : 5 months, 3 weeks ago IST
New Delhi (India) [India], April 5 (ANI): Pharmaceutical Company Zydus Cadila on Monday informed that it has sought approval of the Drugs Controller General of India (DGCI) for using its hepatitis drug for the treatment of coronavirus.
Updated : 8 months, 2 weeks ago IST
New Delhi [India], January 10 (ANI): As many as 215 people have been arrested in the last two months by the Directorate General of GST Intelligence (DGGI) and the CGST Commissionerates in their concerted drive across the country against GST fake invoice frauds.
Updated : 8 months, 3 weeks ago IST
New Delhi [India], January 4 (ANI): In its permission to Serum Institute of India for "manufacture for sale or distribution" of COVID-19 vaccine 'Covishield', the DGCI has said that the second dose should be administered between four to six weeks after the first dose and also noted that the
Updated : 1 year, 1 month ago IST
Pune (Maharashtra) [India], Aug 23 (ANI): The current claims over the Coronavirus vaccine, Covishield, are completely false and it will be commercialised when trials prove successful and regulatory approvals are in place, said Serum Institute of India (SII) on Sunday.
Panaji (Goa) [India], Aug 4 (ANI): Goa has made a new breakthrough in its plasma therapy for critically ill COVID-19 patients after Drugs Controller General of India (DGCI) gave its approval for using Apheresis machine to extract blood plasma, said Health Minister Vishwajit P Rane.
Updated : 1 year, 2 months ago IST
New Delhi, July 26 (ANI): Even as the Drugs Controller General of India (DCGI) has given permission to Itolizumab drug for restricted emergency use on moderate to severe COVID-19 patients, the Union Health Ministry has decided not to include the drug in the national treatment protocol for co